2019
DOI: 10.1590/0004-282x20190051
|View full text |Cite
|
Sign up to set email alerts
|

Employment status of people diagnosed with multiple sclerosis in Brazil

Abstract: Objective: To describe the employment status of Brazilians with multiple sclerosis (MS). Methods: Analysis of a cross-sectional online survey including questions on demographic and occupational status at the time of diagnosis and survey completion, and time from the first symptom to diagnosis. Results: Of those who answered the survey, 804 Brazilians with MS were included. Median age of onset and current age were 28.3 and 36.2 years; median time to diagnosis and disease duration were 2.7 and 7.9 years; 67% h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
4
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 19 publications
0
4
0
1
Order By: Relevance
“…The overall pooled estimate of the prevalence of early retirement was 17.2% (CI 95% 14.6–20.2, I 2 = 99.13). The three countries with the highest effect sizes were the Czech Republic (48.9%; 95% CI 45.7–52.2) [ 40 ], Austria (44.4%; 95% CI 41.4–47.5) [ 39 ] and Brazil (37.1%; 95% CI 30.9–43.9) [ 56 ] while Russia (1.5%; 95% CI 0.4–4.5) [ 45 ], France (3.2%; 95% CI 1.9–5.5) [ 86 ] and Iran (3.7%; 95% CI 2.0–6.5) [ 59 ] had the lowest proportions ( Fig 5 ). The geographical distribution of the studies is uneven, with Europe (39, 58.2%) and North America (18, 26.9%) accounting for most of the publications.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The overall pooled estimate of the prevalence of early retirement was 17.2% (CI 95% 14.6–20.2, I 2 = 99.13). The three countries with the highest effect sizes were the Czech Republic (48.9%; 95% CI 45.7–52.2) [ 40 ], Austria (44.4%; 95% CI 41.4–47.5) [ 39 ] and Brazil (37.1%; 95% CI 30.9–43.9) [ 56 ] while Russia (1.5%; 95% CI 0.4–4.5) [ 45 ], France (3.2%; 95% CI 1.9–5.5) [ 86 ] and Iran (3.7%; 95% CI 2.0–6.5) [ 59 ] had the lowest proportions ( Fig 5 ). The geographical distribution of the studies is uneven, with Europe (39, 58.2%) and North America (18, 26.9%) accounting for most of the publications.…”
Section: Resultsmentioning
confidence: 99%
“…Austria [39], Czech Republic [40], Greece [41], Hungary [42], Kuwait [43], Portugal [44], Russia [45], and Argentina [46] each contributed with one (0.6%) publication reporting the prevalence of unemployed subjects. Ireland [47,48], Israel [49,50], Poland [51,52], and Saudi Arabia [53,54] contributed with two (1.3%) studies each while Brazil [55][56][57], Iran [58][59][60], Holland [61][62][63], Norway [11, 64,65], and Switzerland [66][67][68] contributed with [44] accounted for the highest values. There was a statistically significant difference between the effect sizes of countries (p < 0.001) (Fig 4).…”
Section: Plos Onementioning
confidence: 99%
“…Neusser et al reported an estimated total expenditure of 4.3 billion euros annually when considering all interventions enabling work-life integration 41. Studies on the economic impact of MS come from different countries and continents,7 9 42–44 so the interpretation of their findings must necessarily take into account the specific social security systems of different countries.…”
Section: Resultsmentioning
confidence: 99%
“…The impact of MS on work activities has already been evaluated in many studies carried out in different parts of the world 7–10. Calabrese et al demonstrated that workforce participation can decline from 82% to 8% and employment rates vary between 31% and 65%,7 being influenced by factors such as the degree of disability, the duration of disease, the level of education and the type of work activity.…”
Section: Introductionmentioning
confidence: 99%
“…A esclerose múltipla (EM) é uma doença crônica autoimune, inflamatória e desmielinizante que afeta o sistema nervoso central. Sua incidência varia de acordo com a geografia, idade, etnia e sexo e a aparição dos sintomas iniciase no pico da vida produtiva, entre 20 e 40 anos de idade, comprometendo assim a qualidade de vida e a produtividade do paciente, impactando negativamente na autonomia pessoal e situação laboral (ESTRUTTI et al, 2019).…”
Section: Introductionunclassified